Peptides and cofactors studied in cellular-aging, mitochondrial, and NAD+ research — grouped for a neutral look at where the science stands (much of it preclinical). Every claim is sourced on each peptide's guide.
Longevity peptides are studied for the cellular processes thought to underlie aging — mitochondrial function, NAD+ metabolism, telomere maintenance, and oxidative-stress management. This is the most explicitly experimental pillar: the goal is healthy lifespan, and most of the relevant biology is mapped out in cells and animals rather than proven in people.
It's important to separate mechanism from outcome here. Many of these compounds show promising effects on aging markers in the lab, but translating that into measurable longevity in humans is unproven. Treat the claims as research findings, not anti-aging promises.
NAD+ cofactor central to cellular-energy and sirtuin pathways studied in aging research.
NAD+-pathway modulator studied for metabolic and muscle-aging markers.
Mitochondrial-targeted peptide studied for mitochondrial function.
Studied for telomere and pineal-aging markers.
NAD+ and its precursors have the most human data, mostly on safety and biomarkers rather than on extending lifespan. 5-Amino-1MQ, a modulator of the same NAD+ pathway, is largely preclinical. SS-31 (elamipretide) is the most clinically advanced of the mitochondrial-targeted peptides, with trials in kidney and cardiac conditions.
Epitalon is studied for telomere and pineal-aging markers but, as in the sleep pillar, rests on early work. The throughline: lots of mechanism, not yet much proven human outcome.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.